Exact Mass: 300.151407

Exact Mass Matches: 300.151407

Found 152 metabolites which its exact mass value is equals to given mass value 300.151407, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

p-(1-Methyl-2,2-diphenylvinyl)anisole

1,1-Diphenyl-2-(4-methoxyphenyl)propene

C22H20O (300.151407)


   

Bifenazate

Pesticide3_Bifenazate_C17H20N2O3_1-Methylethyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate

C17H20N2O3 (300.147385)


Bifenazate is a carbazate acaricide that control 100\% of mites at a concentration of 25 ppm[1]. Bifenazate is a positive allosteric modulator of GABA receptor[2].

   

dapdiamide A

Dapdiamide A; 3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-valine

C12H20N4O5 (300.143363)


A member of the family of dapdiamides consisting of alanylvaline in which one of the methyl hydrogens of alanine is replaced by a fumaramoyl group.

   

N-(4-Amino-2,5-diethoxyphenyl)benzamide

N-(4-amino-2,5-diethoxyphenyl)benzenecarboximidic acid

C17H20N2O3 (300.147385)


   

Azapropazone

7-(dimethylamino)-12-methyl-4-propyl-2,6,8-triazatricyclo[7.4.0.0²,⁶]trideca-1(9),7,10,12-tetraene-3,5-dione

C16H20N4O2 (300.158618)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents

   

2-trans,-6-trans-farnesyl monophosphate

2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, dihydrogen phosphoric acid, (e,e)

C15H25O4P (300.149038)


2-trans,-6-trans-farnesyl monophosphate, also known as (2e,6e)-farnesyl phosphate or (2e,6e)-farnesol monophosphoric acid(2-), is a member of the class of compounds known as sesquiterpenoids. Sesquiterpenoids are terpenes with three consecutive isoprene units. 2-trans,-6-trans-farnesyl monophosphate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). 2-trans,-6-trans-farnesyl monophosphate can be found in a number of food items such as opium poppy, papaya, pepper (c. frutescens), and corn, which makes 2-trans,-6-trans-farnesyl monophosphate a potential biomarker for the consumption of these food products.

   
   

Ficusolide diacetate

Ficusolide diacetate

C15H24O6 (300.1572804)


   

Cycloparvifloralone

Cycloparvifloralone

C15H24O6 (300.1572804)


   

Debenzoyldunnianin

Debenzoyldunnianin

C15H24O6 (300.1572804)


   
   
   
   
   
   

(2Z,4E)-3-methyl-5-(1,2,4-trihydroxy-2-hydroxymethyl-6,6-dimethylcyclohexyl)penta-2,4-dienoic acid|monaspilosuslin

(2Z,4E)-3-methyl-5-(1,2,4-trihydroxy-2-hydroxymethyl-6,6-dimethylcyclohexyl)penta-2,4-dienoic acid|monaspilosuslin

C15H24O6 (300.1572804)


   

debenzoyl-7-deoxo-1alpha,7alpha-dihydroxytashironin

debenzoyl-7-deoxo-1alpha,7alpha-dihydroxytashironin

C15H24O6 (300.1572804)


   
   
   

(+)-syributin 2|Syributin 2

(+)-syributin 2|Syributin 2

C15H24O6 (300.1572804)


   

1,6-Dihydroxy-3-deoxyminwanensin

1,6-Dihydroxy-3-deoxyminwanensin

C15H24O6 (300.1572804)


   
   
   
   

1,3-bis(4-methoxybenzyl)urea

1,3-bis(4-methoxybenzyl)urea

C17H20N2O3 (300.147385)


   

7-acetoxy-2-acetyl-1,1-dimethyl-2,3,4,9-tetrahydro-1H-beta-carboline

7-acetoxy-2-acetyl-1,1-dimethyl-2,3,4,9-tetrahydro-1H-beta-carboline

C17H20N2O3 (300.147385)


   

3,5-Dihydroxy-5-heptyl-2,3,3a,5,5a,8-hexahydro-6H-1,4,7-trioxacyclopenta[c]pentalene-6-one

3,5-Dihydroxy-5-heptyl-2,3,3a,5,5a,8-hexahydro-6H-1,4,7-trioxacyclopenta[c]pentalene-6-one

C15H24O6 (300.1572804)


   

7-deoxy-7beta-hydroxypseudoanisatin

7-deoxy-7beta-hydroxypseudoanisatin

C15H24O6 (300.1572804)


   

8-Deoxymerrilliortholactone

8-Deoxymerrilliortholactone

C15H24O6 (300.1572804)


   
   
   
   
   
   
   
   
   
   

Hydroxylupanine HCl

(1R,2S,9R,10S,12S)-12-hydroxy-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecan-6-one;hydrochloride

C15H25ClN2O2 (300.160446)


   

Tetracaine hydrochloride

Tetracaine hydrochloride (Pontocaine)

C15H25ClN2O2 (300.160446)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

NCGC00347773-02!1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

C15H24O6 (300.1572804)


   

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

C15H24O6 (300.1572804)


   

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol_major

1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol_major

C15H24O6 (300.1572804)


   

Ala Gly Gly Pro

(2S)-1-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetyl)pyrrolidine-2-carboxylic acid

C12H20N4O5 (300.143363)


   

Ala Gly Pro Gly

2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}acetic acid

C12H20N4O5 (300.143363)


   

Ala Pro Gly Gly

2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)acetic acid

C12H20N4O5 (300.143363)


   

Gly Ala Gly Pro

(2S)-1-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetyl}pyrrolidine-2-carboxylic acid

C12H20N4O5 (300.143363)


   

Gly Ala Pro Gly

2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C12H20N4O5 (300.143363)


   

Gly Gly Ala Pro

(2S)-1-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanoyl]pyrrolidine-2-carboxylic acid

C12H20N4O5 (300.143363)


   

Gly Gly Pro Ala

(2S)-2-{[(2S)-1-[2-(2-aminoacetamido)acetyl]pyrrolidin-2-yl]formamido}propanoic acid

C12H20N4O5 (300.143363)


   

Gly Pro Ala Gly

2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]acetic acid

C12H20N4O5 (300.143363)


   

Gly Pro Gly Ala

(2S)-2-(2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C12H20N4O5 (300.143363)


   
   

Pro Ala Gly Gly

2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}acetic acid

C12H20N4O5 (300.143363)


   

Pro Gly Ala Gly

2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]acetic acid

C12H20N4O5 (300.143363)


   

Pro Gly Gly Ala

(2S)-2-(2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}acetamido)propanoic acid

C12H20N4O5 (300.143363)


   
   
   
   
   

methyl (E)-2-methyl-4-((3aS)-1-methyl-5-oxo-2,3,5,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-enoate

methyl (E)-2-methyl-4-((3aS)-1-methyl-5-oxo-2,3,5,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-enoate

C17H20N2O3 (300.147385)


   

Zinndiol: 1-[4,5-Bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methyl-2,3-butanediol

Zinndiol: 1-[4,5-Bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methyl-2,3-butanediol

C15H24O6 (300.1572804)


   

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enoic acid

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enoic acid

C15H24O6 (300.1572804)


   

3-Benzamidophenyliminodiethanol

3-Benzamidophenyliminodiethanol

C17H20N2O3 (300.147385)


   

(2-hydroxypropyl)ammonium dihydrogen orthoborate

(2-hydroxypropyl)ammonium dihydrogen orthoborate

C17H20N2O3 (300.147385)


   

[2-(2-methyl-3-nitro-phenyl)-ethyl]-dipropyl-amine hydrochloride

[2-(2-methyl-3-nitro-phenyl)-ethyl]-dipropyl-amine hydrochloride

C15H25ClN2O2 (300.160446)


   

Azoic Diazo No.20

N-(4-Amino-2,5-diethoxyphenyl)benzamide

C17H20N2O3 (300.147385)


   

3-[1,1-Biphenyl]-4-yl-1,2,3,4-tetrahydro-1-naphthol

3-[1,1-Biphenyl]-4-yl-1,2,3,4-tetrahydro-1-naphthol

C22H20O (300.151407)


   

poly(ethylene-co-acrylic acid)

poly(ethylene-co-acrylic acid)

C15H24O6 (300.1572804)


   

Tri(propylene glycol) diacrylate

Tri(propylene glycol) diacrylate

C15H24O6 (300.1572804)


   

methyl 4-[(2-butyl-5-formylimidazol-1-yl)methyl]benzoate

methyl 4-[(2-butyl-5-formylimidazol-1-yl)methyl]benzoate

C17H20N2O3 (300.147385)


   

Benzoic acid,2-hydroxy-, compd. with 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine (1:1)

Benzoic acid,2-hydroxy-, compd. with 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine (1:1)

C17H20N2O3 (300.147385)


   

2,2-[[4-[(4-aminophenyl)azo]phenyl]imino]bisethanol

2,2-[[4-[(4-aminophenyl)azo]phenyl]imino]bisethanol

C16H20N4O2 (300.158618)


   
   

Itasetron

Itasetron

C16H20N4O2 (300.158618)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

1-(4-Hydroxyphenyl)-1,2-diphenyl-1-butene

1-(4-Hydroxyphenyl)-1,2-diphenyl-1-butene

C22H20O (300.151407)


   
   

Azapropazone

Azapropazone

C16H20N4O2 (300.158618)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents

   

(R)-N-methylcoclaurinium

(R)-N-methylcoclaurinium

C18H22NO3+ (300.1599602)


   

(S)-N-methylcoclaurinium(1+)

(S)-N-methylcoclaurinium(1+)

C18H22NO3+ (300.1599602)


The conjugate acid of (S)-N-methylcoclaurine; major species at pH 7.3.

   

Codeine(1+)

Codeine(1+)

C18H22NO3+ (300.1599602)


The conjugate acid of codeine arising from protonation of the tertiary amino group; major species at pH 7.3.

   

(2E,6E)-Farnesyl phosphate

(2E,6E)-Farnesyl phosphate

C15H25O4P-2 (300.149038)


   

(2S)-2-[[(2S)-2-[[(E)-4-amino-4-oxobut-2-enoyl]amino]-3-azaniumylpropanoyl]amino]-3-methylbutanoate

(2S)-2-[[(2S)-2-[[(E)-4-amino-4-oxobut-2-enoyl]amino]-3-azaniumylpropanoyl]amino]-3-methylbutanoate

C12H20N4O5 (300.143363)


   

tyramine 4-O-beta-D-glucoside

tyramine 4-O-beta-D-glucoside

C14H22NO6+ (300.1447052)


   
   

[3-Carboxy-2-[3-(carboxymethyl)-2-methylidenebut-3-enoyl]oxypropyl]-trimethylazanium

[3-Carboxy-2-[3-(carboxymethyl)-2-methylidenebut-3-enoyl]oxypropyl]-trimethylazanium

C14H22NO6+ (300.1447052)


   
   
   

5-(4-ethoxyphenyl)-N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,3,4-oxadiazol-2-amine

5-(4-ethoxyphenyl)-N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,3,4-oxadiazol-2-amine

C16H20N4O2 (300.158618)


   

N-methyl-N-[(E)-(2,4,5-trimethoxyphenyl)methylideneamino]aniline

N-methyl-N-[(E)-(2,4,5-trimethoxyphenyl)methylideneamino]aniline

C17H20N2O3 (300.147385)


   
   
   
   
   
   

(5R,8R)-8-methyl-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5R,8R)-8-methyl-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C16H20N4O2 (300.158618)


   

(7S)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(7S)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.158618)


   

(4R,7S)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7S)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.158618)


   

(4R,7R)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.158618)


   

(5S)-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5S)-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C16H20N4O2 (300.158618)


   

(7R)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(7R)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C16H20N4O2 (300.158618)


   
   
   
   
   
   

Drimenol phosphate(2-)

Drimenol phosphate(2-)

C15H25O4P-2 (300.149038)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-7H-purin-1-ium-6-amine

N-[2-(3,4-dimethoxyphenyl)ethyl]-7H-purin-1-ium-6-amine

C15H18N5O2+ (300.1460428)


   

[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-1,3a,4,5,8,9-hexahydropyrrolo[1,2-c]purin-7-ium-4-yl]methyl carbamate

[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-1,3a,4,5,8,9-hexahydropyrrolo[1,2-c]purin-7-ium-4-yl]methyl carbamate

C10H18N7O4+ (300.1420208)


   

[(3aS,4R,9S,10R,10aS)-2,6-diamino-9,10-dihydroxy-3a,4,5,8,9,10-hexahydro-1H-pyrrolo[1,2-c]purin-7-ium-4-yl]methyl carbamate

[(3aS,4R,9S,10R,10aS)-2,6-diamino-9,10-dihydroxy-3a,4,5,8,9,10-hexahydro-1H-pyrrolo[1,2-c]purin-7-ium-4-yl]methyl carbamate

C10H18N7O4+ (300.1420208)


   

2-[Hydroxy-(2-hydroxy-3-propoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-hydroxy-3-propoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C11H27NO6P+ (300.1575912)


   

(2E,6E)-farnesyl monophosphate(2-)

(2E,6E)-farnesyl monophosphate(2-)

C15H25O4P (300.149038)


An organophosphate oxoanion that is the dianion obtained by removal of the two protons from the monophosphate group of (2E,6E)-farnesyl monophosphate. Major species at pH 7.3.

   

dapdiamide A zwitterion

dapdiamide A zwitterion

C12H20N4O5 (300.143363)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of dapdiamide A; major species at pH 7.3.

   

neopine(1+)

neopine(1+)

C18H22NO3 (300.1599602)


An ammonium ion derivative that is the conjugate acid of neopine arising from protonation of the tertiary amino group; major species at pH 7.3.

   

BIA 10-2474

BIA 10-2474

C16H20N4O2 (300.158618)


BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.

   

(2s)-2-{[(2s)-3-amino-1-hydroxy-2-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylbutanoic acid

(2s)-2-{[(2s)-3-amino-1-hydroxy-2-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylbutanoic acid

C12H20N4O5 (300.143363)


   

(2's,3s)-2-hydroxy-2'-(3-oxopentyl)spiro[indole-3,3'-pyrrolidine]-1'-carbaldehyde

(2's,3s)-2-hydroxy-2'-(3-oxopentyl)spiro[indole-3,3'-pyrrolidine]-1'-carbaldehyde

C17H20N2O3 (300.147385)


   

(3as,5r,5as,7r,8s,9r,9as,9br)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

(3as,5r,5as,7r,8s,9r,9as,9br)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

C15H24O6 (300.1572804)


   

(3r,4s,5r)-3-hydroxy-8-oxo-1,7-dioxaspiro[4.4]nonan-4-yl octanoate

(3r,4s,5r)-3-hydroxy-8-oxo-1,7-dioxaspiro[4.4]nonan-4-yl octanoate

C15H24O6 (300.1572804)


   

1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol

1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol

C15H24O6 (300.1572804)


   

(1r,3r,4r,5r,6r,7s,11r)-3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one

(1r,3r,4r,5r,6r,7s,11r)-3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one

C15H24O6 (300.1572804)


   

(2r,3r)-2,3-dihydroxy-3-(5-oxo-2h-furan-3-yl)propyl octanoate

(2r,3r)-2,3-dihydroxy-3-(5-oxo-2h-furan-3-yl)propyl octanoate

C15H24O6 (300.1572804)


   

n'-{5-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]naphthalen-1-yl}-n,n-dimethylcarbamimidic acid

n'-{5-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]naphthalen-1-yl}-n,n-dimethylcarbamimidic acid

C16H20N4O2 (300.158618)


   

(1s,2r,5r,6s,8r,10s,13r,14r)-1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol

(1s,2r,5r,6s,8r,10s,13r,14r)-1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol

C15H24O6 (300.1572804)


   

(2s)-1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

(2s)-1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol

C15H24O6 (300.1572804)


   

(1s,4as,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

(1s,4as,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

C15H24O6 (300.1572804)


   

(1r,2r,4s,5r,6r,12r,13r)-4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one

(1r,2r,4s,5r,6r,12r,13r)-4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one

C15H24O6 (300.1572804)


   

(1r,2s,5r,6s,7s,8r,11r)-11-[(2r)-1,2-dihydroxypropan-2-yl]-7-hydroxy-5-(hydroxymethyl)-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecan-10-one

(1r,2s,5r,6s,7s,8r,11r)-11-[(2r)-1,2-dihydroxypropan-2-yl]-7-hydroxy-5-(hydroxymethyl)-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecan-10-one

C15H24O6 (300.1572804)


   

7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one

7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one

C15H24O6 (300.1572804)


   

1-(dimethylamino)-13-ethenyl-5-hydroxy-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraene-11-carboxylic acid

1-(dimethylamino)-13-ethenyl-5-hydroxy-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraene-11-carboxylic acid

C17H20N2O3 (300.147385)


   

(3ar,5s,5ar,7s,8r,9s,9ar,9bs)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

(3ar,5s,5ar,7s,8r,9s,9ar,9bs)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

C15H24O6 (300.1572804)


   

(2s)-4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate

(2s)-4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate

C15H24O6 (300.1572804)


   

(1r,2r,4s,5r,6r,7r,8r)-4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one

(1r,2r,4s,5r,6r,7r,8r)-4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one

C15H24O6 (300.1572804)


   

(1s,4ar,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

(1s,4ar,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

C15H24O6 (300.1572804)


   

4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one

4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one

C15H24O6 (300.1572804)


   

5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol

C15H24O6 (300.1572804)


   

2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol

2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol

C15H24O6 (300.1572804)


   

4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate

4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate

C15H24O6 (300.1572804)


   

6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid

C15H24O6 (300.1572804)


   

3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one

3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one

C15H24O6 (300.1572804)


   

{4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,4,7-tetraen-6-ylidene}(methyl)oxidanium

{4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,4,7-tetraen-6-ylidene}(methyl)oxidanium

[C18H22NO3]+ (300.1599602)


   

(1r,4r,5s,7r,8s)-7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one

(1r,4r,5s,7r,8s)-7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one

C15H24O6 (300.1572804)


   

2-acetyl-1,1-dimethyl-3h,4h,9h-pyrido[3,4-b]indol-7-yl acetate

2-acetyl-1,1-dimethyl-3h,4h,9h-pyrido[3,4-b]indol-7-yl acetate

C17H20N2O3 (300.147385)


   

(1r,9r,13r)-1-(dimethylamino)-13-ethenyl-5-hydroxy-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraene-11-carboxylic acid

(1r,9r,13r)-1-(dimethylamino)-13-ethenyl-5-hydroxy-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraene-11-carboxylic acid

C17H20N2O3 (300.147385)


   

n,n'-bis[(4-methoxyphenyl)methyl]carbamimidic acid

n,n'-bis[(4-methoxyphenyl)methyl]carbamimidic acid

C17H20N2O3 (300.147385)


   

4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one

4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one

C15H24O6 (300.1572804)


   

(1r,2s,5s,6s,9s,10s,11s,13r)-2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol

(1r,2s,5s,6s,9s,10s,11s,13r)-2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol

C15H24O6 (300.1572804)


   

(1r,2s,6r,7r,8s,9r,11s,12r)-1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol

(1r,2s,6r,7r,8s,9r,11s,12r)-1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol

C15H24O6 (300.1572804)


   

1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol

1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol

C15H24O6 (300.1572804)